Improving GHB withdrawal with baclofen: study protocol for a feasibility study for a randomised controlled trial

about

Baclofen in gamma-hydroxybutyrate withdrawal: patterns of use and online availability.Baclofen to Prevent Relapse in Gamma-Hydroxybutyrate (GHB)-Dependent Patients: A Multicentre, Open-Label, Non-Randomized, Controlled Trial.

P2860

Q47379292-F105AA61-E502-4A10-88E5-1095DD062715 Q52317686-58574FD6-84D6-4251-AFE9-163A095C724C

P2860

Improving GHB withdrawal with baclofen: study protocol for a feasibility study for a randomised controlled trial

Item

http://www.wikidata.org/entity/Q37291754

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Improving GHB withdrawal with ...... a randomised controlled trial

@en

Improving GHB withdrawal with ...... a randomised controlled trial.

@nl

type

Item

label

Improving GHB withdrawal with ...... a randomised controlled trial

@en

Improving GHB withdrawal with ...... a randomised controlled trial.

@nl

prefLabel

Improving GHB withdrawal with ...... a randomised controlled trial

@en

Improving GHB withdrawal with ...... a randomised controlled trial.

@nl

P1476

Improving GHB withdrawal with ...... a randomised controlled trial

@en

P2093

Fabiana Gordon

http://www.w3.org/2001/XMLSchema#string

Owen Bowden-Jones

http://www.w3.org/2001/XMLSchema#string

Paul I Dargan

http://www.w3.org/2001/XMLSchema#string

Steve Parrott

http://www.w3.org/2001/XMLSchema#string

Yash Patel

http://www.w3.org/2001/XMLSchema#string

P2860

The PHQ-9: validity of a brief depression severity measure

Baclofen and gamma-hydroxybutyrate withdrawal

Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II

What is chemsex and why does it matter?

A comparison of recreational drug use amongst sexual health clinic users in London with existing prevalence data.

Gamma-hydroxybutyrate withdrawal syndrome.

GHB: a new and novel drug of abuse.

BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP.

Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence.

Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).

P2888

s13063-016-1593-9

P304

472

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13063-016-1593-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1036980439

http://www.w3.org/2001/XMLSchema#string

P698

27677382

http://www.w3.org/2001/XMLSchema#string

P921

Feasibility study

P932

5039898

http://www.w3.org/2001/XMLSchema#string

Improving GHB withdrawal with baclofen: study protocol for a feasibility study for a randomised controlled trial

about

P2860

P2860

Improving GHB withdrawal with baclofen: study protocol for a feasibility study for a randomised controlled trial

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932